Keeping You Updated
Here is a selection of recent PharmaVentures press releases...
Deal-making declines by 18% in a year as pharmaceutical companies tighten their belt
Oxford, UK 25 January 2012 - Overall pharmaceutical deal-making activity fell by 18% in 2011 as pharmaceutical companies cut R&D expenditure and streamlined their research and development activities, according to research conducted by the UK advisory firm PharmaVentures.
PharmaVentures helps secure investor for former MSD research site
Oxford, UK 19 January 2012 - PharmaVentures announced today that it was delighted to act as transaction advisor to MSD (operating in the US and Canada as Merck & Co) to secure its deal with BioCity Scotland, a new joint venture between BioCity Nottingham and Roslin BioCentre, for the former MSD research facility in Newhouse, Lanarkshire.
PharmaVentures’ client Sanofi wins Scrip ‘Outsourcing Deal of the Year Award’
Oxford, UK 12 January 2012 - PharmaVentures announced today that it was delighted to play an advisory role in the Sanofi – Covance deal which won Scrip’s ‘Outsourcing Deal of the Year 2011’.
Pfizer, Sanofi and Genentech feature prominently in the Oncology edition of PharmaDeals’ new publication series; Essential Deal Trends
Oxford, UK 20 October 2011 - PharmaVentures today announced the launch of PharmaDeals® Essential Deal Trends: Oncology 2011. This new series of reports is essential reading for everyone involved in developing and commercialising new drugs. The first report in the series focuses on oncology.